Biotech | February 13, 2021
Biocon Biologics and Viatris receive European Commission approval for Kixelle, Biosimilar Insulin Aspart
The centralized marketing authorization granted by the EC is valid in all EU Member
The centralized marketing authorization granted by the EC is valid in all EU Member
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
NEJM study shows strong protection across strains
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
Subscribe To Our Newsletter & Stay Updated
